SRI Biosciences
@SRI_Biosciences
Followers
60
Following
162
Media
12
Statuses
60
Division of @SRI_Intl developing next-gen drugs, diagnostics & devices to solve unmet medical needs and provide solutions for challenging therapeutic problems.
Menlo Park, CA
Joined October 2022
SRI’s new brand marks more than 75 years of world-changing technologies, services, and ideas. Learn more about us: https://t.co/LNqOXJ7JOR Follow us here: LinkedIn: https://t.co/x0KLTMdL5O Facebook: https://t.co/ENhSFrUlWt
0
5
10
SRI Biosciences' Elisabeth Perea is collaborating under DARPA’s Cornucopia program, known as Food from Air for Distributed Rations (FADR), to produce food quickly with minimal inputs in disaster relief situations or military operations. Read the story:
sri.com
Food from Air for Distributed Meals (FADR) seeks to produce nutritious food on-demand, aiding disaster relief efforts and military operations.
0
1
1
#DYK SRI developed a treatment for drug-resistant malaria, called halofantrine? Discovered in the 1960s and approved by the FDA in 1992, the drug was an important addition to the drug arsenal in the early years of malaria treatment. More: https://t.co/gvTROzZsyB
#WorldMalariaDay
sri.com
SRI developed halofantrine for the U.S. Army from 1965 to 1975 as a treatment for drug-resistant malaria.
0
0
0
Today is @WHO World Health Day. #COVID19 set back every country’s journey to #HealthForAll. SRI's Immunology & Virology Director, Mary Lanier, continues to lead programs to develop effective anti-viral and immune therapeutic compounds against COVID. More:
0
0
1
SRI developed the DxCell-Complex platform for testing individuals for exposure to viral infections. This will enable rapid & cost-effective manufacturing & use in healthcare facilities. We recently validated its efficacy against #COVID19 infection. More👇
aiche.onlinelibrary.wiley.com
We have developed a serology test platform for identifying individuals with prior exposure to specific viral infections and provide data to help reduce public health risks. The serology test compos...
0
0
0
We're at @SOToxicology conference this week! Stop by booth #1642 to learn about our toxicology and pharmacology R&D services. Not at #2023sot and want to learn more? Visit https://t.co/aKmcQkUh0o
0
0
2
SRI's Human Sleep Research Program is shedding light on sleep disturbance during menopause. A review by @FionaCBaker1 shows how the decline of postmenopausal estrogen and progesterone contributes to sleep disturbances in women. More here: https://t.co/jHyYRO7Tfj
#WorldSleepDay
sri.com
Results demonstrated that the postmenopausal decline in estrogen and progesterone contributes to sleep disturbances in women.
0
0
1
Read our latest profile on Kathlynn Brown, SRI Biosciences' first female president, in which she discusses her career path, achievements, and how passion and hard work can help tackle difficult scientific challenges. #InternationalWomensDay #IWD2023
https://t.co/fijjJxc9V8
0
1
0
This week at @SLAS_Org Conference we presented @DARPA funded work using our chemistry automation platform, Synfini™, to turn virtual molecules into physical compounds. Not at #SLAS2023 but want to learn more? Visit: https://t.co/2QkATcpxEF
@Molecreationist #drugdiscovery
0
0
7
We'll be at @BiocomCA Global Life Sci Partnering & Investor Conference discussing our targeted intracellular #drugdelivery platform, FOX Three. Our new @NatureComms paper shows FOX Three effectively delivers anticancer agents to targeted cells. Read here: https://t.co/toPkoEBt5W
0
0
1
SRI Biosciences is now on LinkedIn. Follow along for division news, research updates, and involvements: https://t.co/5KgT8I1Buu
#precisionmedicine #biomedicalresearch #drugdiscovery
linkedin.com
SRI Biosciences | 1,225 followers on LinkedIn. Developing next-gen drugs, diagnostics, and technologies to solve unmet medical needs and propel innovation to market. | SRI Biosciences—a division of...
0
1
1
Join us next week on Thursday, Feb. 23rd at 1 pm EST to learn about our #precisionmedicine platform, DiaCyt, which can identify peptides that deliver treatment through the highly selective blood-brain barrier without destruction of its biological cargo. Sign up for free👇
Do not miss this webinar from @SRI_Biosciences to learn how combining the MTS and MGS peptides allows for both transport and cell-specific targeting within the CNS. https://t.co/HeoszIhJCB
#NeurodegenerativeDisease #CNS #DrugDelivery
0
0
2
We're looking for women ages 18-35 to participate in an @NIH funded research study that aims to explore the impact of sex hormones on memory & sleep. Take our confidential survey to find out if you are eligible for the study👇 https://t.co/egUoNMAUYR
0
1
2
Join us Feb 23rd at 1 pm EST for @Xtalks webinar by our incoming president, Dr. Kathlynn Brown, titled, "Going Beyond the Blood-Brain Barrier: Delivery of Diverse Cargo to Targeted Cells Within the Central Nervous System." Learn more and sign up for free👇 https://t.co/421ycKKrtQ
xtalks.com
Register today to learn more about going beyond the blood-brain barrier through the delivery of diverse cargo within the central nervous system.
0
2
3
On @UICC #WorldCancerDay we reimagine a world with effective cancer prevention and life-saving treatment & care. SRI is doing important work in treating cancer by developing a peptide that targets lung tumors and delivers therapeutics inside cells. More👇 https://t.co/Fg8vMVID6q
sri.com
The newly optimized molecular vehicle provides effective, targeted delivery of anticancer agents to lung tumors.
0
0
1
Are you a working #woman between the ages of 40–65 years old? Help us to investigate #menopause in the #workplace! -------- Follow this link to start the #survey: https://t.co/VC5pHJ20Pi -------- #employers #stress #sleep #health #wellness @MiddayHealth @SRI_Biosciences
0
7
9
We're excited to announce the promotion of Kathlynn Brown as President of SRI's Biosciences Division. Kathlynn is a recognized leader in life sciences research areas of organic chemistry, peptide chemistry, biochemistry and molecular biology. Read more👉 https://t.co/A42uvCynku
0
0
4
About 1/3 of the US population reports regular use of consumer #sleep technology wearables to track sleep, physical activity & other health indicators. Our recent publication discusses performance, rationale, theoretical & practical guidelines for testing & using wearable CST👇
Performance of consumer #wearable #sleep #technology @cathygo_sleep @LuMenPsy @FionaCBaker1 @SRI_Intl @MiddayHealth
0
0
2
Are you a working #woman between the ages of 40–65 years old? Help us to investigate #menopause in the #workplace! Follow this link to start the survey: https://t.co/VC5pHJ20Pi. - - - SRI International (@SRI_Intl) & Lisa Health ( https://t.co/JCtvSnBK5J | @MiddayHealth)
0
7
8
Our Human Sleep Research Lab studies whether wearable #sleep technologies can accurately, consistently & reliably capture sleep metrics, such as sleep quality & and quantity. Learn more about the important role of sleep wearables in future research👇 https://t.co/S04IuHOALv
0
0
2